Ghost Tree Capital, LLC Provention Bio, Inc. Transaction History

Ghost Tree Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.52 - $10.57 $1.81 Million - $4.23 Million	400,000 New	400,000 $4.23 Million
Q4 2021 Feb 16, 2022	SELL	$5.59 - $7.39 $279,500 - $369,500	-50,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.66 - $8.33 $283,000 - $416,500	-50,000 Reduced 50.0%	50,000 $320,000
Q2 2021 Aug 11, 2021	BUY	$6.71 - $11.04 $671,000 - $1.1 Million	100,000 New	100,000 $843,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.